Alyeska Investment Group’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Hold |
0
| – | – | – | 578 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 547 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 448 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 461 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 457 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 486 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 414 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 423 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 474 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 489 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 481 |
|
|
2017
Q4 | – | Sell |
-201
| Closed | -$1.64M | – | 494 |
|
|
2017
Q3 | $1.64M | Sell |
201
-260
| -56% | -$2.12M | 0.01% | 354 |
|
|
2017
Q2 | $2.28M | Sell |
461
-14
| -3% | -$69.3K | 0.02% | 323 |
|
|
2017
Q1 | $2.62M | Sell |
475
-49
| -9% | -$271K | 0.02% | 363 |
|
|
2016
Q4 | $3.5M | Buy |
+524
| New | +$3.5M | 0.03% | 347 |
|
|
2015
Q4 | – | Sell |
-31
| Closed | -$625K | – | 452 |
|
|
2015
Q3 | $625K | Buy |
+31
| New | +$625K | 0.01% | 408 |
|